Literature DB >> 1900227

A new class of reversible cell cycle inhibitors.

B D Hoffman1, H M Hanauske-Abel, A Flint, M Lalande.   

Abstract

The effects of three compounds on the cell cycle of HL-60 promyeloid leukemia cells has been examined. Ciclopirox olamine, an antifungal agent, and the compound Hoechst 768159 reversibly block the cell cycle at a point occurring roughly 1 h before the arrest mediated by aphidicolin, an inhibitor of DNA polymerase alpha activity, which acts in early S phase. Similar results are also obtained with the compound mimosine, a plant amino acid. Based on these data, it is concluded that all three agents inhibit cell cycle traverse at or very near the G1/S phase boundary and identify a previously undefined reversible cell cycle arrest point.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900227     DOI: 10.1002/cyto.990120105

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  20 in total

1.  Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.

Authors:  R Sarid; J S Wiezorek; P S Moore; Y Chang
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

2.  The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia telangiectasia and normal human cells.

Authors:  V F Liu; D T Weaver
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

Review 3.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

4.  The antitumor activity of the fungicide ciclopirox.

Authors:  Hongyu Zhou; Tao Shen; Yan Luo; Lei Liu; Wenxing Chen; Baoshan Xu; Xiuzhen Han; Jia Pang; Chantal A Rivera; Shile Huang
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

5.  Accumulation of HL-60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline.

Authors:  D J Watters; H J Beamish; K A Marshall; R A Gardiner; G J Seymour; M F Lavin
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle.

Authors:  R L Marraccino; E J Firpo; J M Roberts
Journal:  Mol Biol Cell       Date:  1992-04       Impact factor: 4.138

7.  Determination of DNA replication kinetics in synchronized human cells using a PCR-based assay.

Authors:  D Sinnett; A Flint; M Lalande
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

8.  Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells.

Authors:  K Hanashiro; M Kanai; Y Geng; P Sicinski; K Fukasawa
Journal:  Oncogene       Date:  2008-05-19       Impact factor: 9.867

9.  A general protocol for evaluating the specific effects of DNA replication inhibitors.

Authors:  V Levenson; J L Hamlin
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

10.  Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.

Authors:  Elisabeth Mémin; Mainul Hoque; Mohit R Jain; Debra S Heller; Hong Li; Bernadette Cracchiolo; Hartmut M Hanauske-Abel; Tsafi Pe'ery; Michael B Mathews
Journal:  Cancer Res       Date:  2013-11-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.